TNXP icon

Tonix Pharmaceuticals
TNXP

Overview Fund Trends Analyst Outlook Journalist POV

hedge funds and large institutions have $6.07M invested in Tonix Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$104K
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$364K
2
-$327K
3
-$250K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$47K
5
Goldman Sachs
Goldman Sachs
New York
-$46K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.1M
2
$1.1M
3
$787K
4
$668K
5
$302K
6
$225K
7
$187K
8
$119K
9
$98K
10
$93K
11
$93K
12
$88K
13
$67K
14
$47K
15
$47K
16
$22K
17
$11K
18
$7K
19
$5K
20
$4K
21
$1K
22
$1K
23
$1K
24
$1K
25
–
1
2